Skip to Content

150 Logo 4357 (Ranitidine Hydrochloride 150 mg)

Pill with imprint 150 Logo 4357 is Beige, Round and has been identified as Ranitidine Hydrochloride 150 mg. It is supplied by Teva Pharmaceuticals USA.

Ranitidine is used in the treatment of gerd; erosive esophagitis; duodenal ulcer; gastric ulcer maintenance treatment; cutaneous mastocytosis (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 150 Logo 4357

Ranitidine hydrochloride 150 mg 150 Logo 4357
Ranitidine hydrochloride 150 mg 150 Logo 4357
Ranitidine hydrochloride 150 mg 150 Logo 4357

Ranitidine Hydrochloride

Imprint:
150 Logo 4357
Strength:
150 mg
Color:
Beige
Size:
9.00 mm
Shape:
Round
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Teva Pharmaceuticals USA
Inactive Ingredients:
croscarmellose sodium
hypromelloses
lactose monohydrate
magnesium stearate
microcrystalline cellulose
ferric oxide red
titanium dioxide
triethyl citrate
ferric oxide yellow
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide